Brett Johnson

Brett Johnson

Research Analyst

Brett Johnson is a Research Analyst at Exome focused on the therapeutics sector. Prior to joining Exome in 2024, he was an investment banking associate at Lazard in the healthcare group as well as a medicinal chemist at both Amgen and Eli Lilly. Mr. Johnson received an MBA from the University of Virginia Darden School of Business, a M.S. in organic chemistry from Boston College and a B.S. in chemistry from the University of Missouri-Columbia.